Literature DB >> 27456843

Radiating hemorrhage in exudative age-related macular degeneration.

Jae Hui Kim1, Young Suk Chang2, Jong Woo Kim3, Tae Gon Lee3, Chul Gu Kim3, Dong Won Lee3.   

Abstract

PURPOSE: To investigate the characteristics of radiating hemorrhage secondary to exudative age-related macular degeneration (AMD) and its clinical significance.
METHODS: This retrospective, observational case series included 288 eyes of 288 patients who initially presented with submacular hemorrhage secondary to exudative AMD. First, we estimated the incidence of radiating hemorrhage; we then compared the incidence of polypoidal choroidal vasculopathy (PCV) compared with that of the other subtypes of AMD. Optical coherence tomography (OCT) images were analyzed to identify the level of hemorrhage. The extent of submacular hemorrhage was compared between eyes with and without radiating hemorrhage.
RESULTS: Radiating hemorrhage was identified in 41 eyes (14.2 %). In 36 of these eyes, the OCT scanning line included the area of radiating hemorrhage. In 31 of these, OCT showed avulsion of the outer retinal layers, including the outer nuclear layer and photoreceptor layer. The outer plexiform layer and inner retinal layer were relatively well preserved. The extent of submacular hemorrhage was significantly smaller in eyes with radiating hemorrhage (mean 4.2 ± 2.9 disc areas) than in eyes without it (mean 8.3 ± 6.2 disc areas) (P < 0.001). In addition, the incidence of radiating hemorrhage was significantly higher in eyes with submacular hemorrhage secondary to PCV (19.4 %) than in those with the other subtypes of AMD (7.5 %; P = 0.025).
CONCLUSIONS: Radiating hemorrhage in exudative AMD was found to be a deep retinal hemorrhage generally accompanied with relatively small-sized submacular hemorrhage. The incidence of this type of hemorrhage was higher in PCV than in the other subtypes of AMD.

Entities:  

Keywords:  Age-related macular degeneration; Choroidal neovascularization; Hemorrhage; Polypoidal choroidal vasculopathy; Radiating hemorrhage

Mesh:

Year:  2016        PMID: 27456843     DOI: 10.1007/s10384-016-0466-9

Source DB:  PubMed          Journal:  Jpn J Ophthalmol        ISSN: 0021-5155            Impact factor:   2.447


  25 in total

1.  EVEREST study: efficacy and safety of verteporfin photodynamic therapy in combination with ranibizumab or alone versus ranibizumab monotherapy in patients with symptomatic macular polypoidal choroidal vasculopathy.

Authors:  Adrian Koh; Won Ki Lee; Lee-Jen Chen; Shih-Jen Chen; Yehia Hashad; Hakyoung Kim; Timothy Y Lai; Stefan Pilz; Paisan Ruamviboonsuk; Erika Tokaji; Annemarie Weisberger; Tock H Lim
Journal:  Retina       Date:  2012-09       Impact factor: 4.256

2.  Visual prognosis of eyes with submacular hemorrhage associated with exudative age-related macular degeneration.

Authors:  Naoko Ueda-Arakawa; Akitaka Tsujikawa; Kenji Yamashiro; Sotaro Ooto; Hiroshi Tamura; Nagahisa Yoshimura
Journal:  Jpn J Ophthalmol       Date:  2012-10-04       Impact factor: 2.447

3.  Ranibizumab versus verteporfin for neovascular age-related macular degeneration.

Authors:  David M Brown; Peter K Kaiser; Mark Michels; Gisele Soubrane; Jeffrey S Heier; Robert Y Kim; Judy P Sy; Susan Schneider
Journal:  N Engl J Med       Date:  2006-10-05       Impact factor: 91.245

4.  Factors associated with the response of age-related macular degeneration to intravitreal ranibizumab treatment.

Authors:  Kenji Yamashiro; Kaoruko Tomita; Akitaka Tsujikawa; Isao Nakata; Yumiko Akagi-Kurashige; Masahiro Miyake; Sotaro Ooto; Hiroshi Tamura; Nagahisa Yoshimura
Journal:  Am J Ophthalmol       Date:  2012-04-01       Impact factor: 5.258

5.  Intravitreal anti-vascular endothelial growth factor for submacular hemorrhage from choroidal neovascularization.

Authors:  Jae Hui Kim; Young Suk Chang; Jong Woo Kim; Chul Gu Kim; Su Jin Yoo; Han Ju Cho
Journal:  Ophthalmology       Date:  2013-12-15       Impact factor: 12.079

6.  Subretinal drusenoid deposits in non-neovascular age-related macular degeneration: morphology, prevalence, topography, and biogenesis model.

Authors:  Christine A Curcio; Jeffrey D Messinger; Kenneth R Sloan; Gerald McGwin; Nancy E Medeiros; Richard F Spaide
Journal:  Retina       Date:  2013-02       Impact factor: 4.256

7.  Prevalence and genomic association of reticular pseudodrusen in age-related macular degeneration.

Authors:  Naoko Ueda-Arakawa; Sotaro Ooto; Isao Nakata; Kenji Yamashiro; Akitaka Tsujikawa; Akio Oishi; Nagahisa Yoshimura
Journal:  Am J Ophthalmol       Date:  2012-10-27       Impact factor: 5.258

8.  Management of submacular hemorrhage secondary to neovascular age-related macular degeneration with anti-vascular endothelial growth factor monotherapy.

Authors:  Gary Shienbaum; Carlos Alexandre A Garcia Filho; Harry W Flynn; Renata Portella Nunes; William E Smiddy; Philip J Rosenfeld
Journal:  Am J Ophthalmol       Date:  2013-03-07       Impact factor: 5.258

9.  Polypoidal choroidal vasculopathy in white patients.

Authors:  Stephen J Davis; Andreas K Lauer; Christina J Flaxel
Journal:  Retina       Date:  2014-11       Impact factor: 4.256

10.  Pneumatic displacement with intravitreal bevacizumab for massive submacular hemorrhage due to polypoidal choroidal vasculopathy.

Authors:  Masayasu Kitahashi; Takayuki Baba; Madoka Sakurai; Hirotaka Yokouchi; Mariko Kubota-Taniai; Yoshinori Mitamura; Shuichi Yamamoto
Journal:  Clin Ophthalmol       Date:  2014-03-03
View more
  3 in total

1.  Quantification of retinal changes after resolution of submacular hemorrhage secondary to polypoidal choroidal vasculopathy.

Authors:  Jae Hui Kim; Young Suk Chang; Dong Won Lee; Chul Gu Kim; Jong Woo Kim
Journal:  Jpn J Ophthalmol       Date:  2017-11-29       Impact factor: 2.447

2.  Neurodegeneration, gliosis, and resolution of haemorrhage in neovascular age-related macular degeneration, a clinicopathologic correlation.

Authors:  Miaoling Li; Rosa Dolz-Marco; Jeffrey D Messinger; Daniela Ferrara; K Bailey Freund; Christine A Curcio
Journal:  Eye (Lond)       Date:  2020-05-04       Impact factor: 3.775

3.  Influence of bevacizumab therapy and intraretinal hemorrhage in long-term outcomes of hemorrhagic retinal arterial macroaneurysm.

Authors:  Jae Hui Kim; Jong Woo Kim; Chul Gu Kim; Young Ju Lew; Han Joo Cho
Journal:  Sci Rep       Date:  2021-07-09       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.